Cargando…

Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV

OBJECTIVES: The aim of this study was to assess the immunogenicity of SARS-CoV-2 available vaccines among people living with HIV (PLWH) after a complete vaccination scheme, and determine predictors of seroconversion. METHODS: This multicentre prospective cohort study included 420 PLWH who had receiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corma-Gómez, Anaïs, Fernández-Fuertes, Marta, García, Estefanía, Fuentes-López, Ana, Gómez-Ayerbe, Cristina, Rivero-Juárez, Antonio, Domínguez, Carmen, Santos, Marta, Viñuela, Laura, Palacios, Rosario, Real, Luis M., Rivero, Antonio, Macías, Juan, Pineda, Juan A., García, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144847/ https://www.ncbi.nlm.nih.gov/pubmed/35640840 http://dx.doi.org/10.1016/j.cmi.2022.05.018

Ejemplares similares

Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV
por: Macías, Juan, et al.
Publicado: (2022)

A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure
por: Corma-Gómez, Anaïs, et al.
Publicado: (2021)

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023)

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023)

Incidence of and factors associated with SARS‐CoV‐2 infection among people living with HIV in Southern Spain after one year of pandemic
por: Fernandez‐Fuertes, Marta, et al.
Publicado: (2021)

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection
por: Real, Luis Miguel, et al.
Publicado: (2019)

Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide
por: Santos, Marta, et al.
Publicado: (2023)

High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
por: Macías, Juan, et al.
Publicado: (2020)

Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection
por: Fernandez-Fuertes, M., et al.
Publicado: (2020)

Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals
por: Rivero-Juárez, Antonio, et al.
Publicado: (2020)

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain
por: Rivero-Juarez, Antonio, et al.
Publicado: (2020)

Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis
por: Macias, Juan, et al.
Publicado: (2022)

Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR
por: Frías, Mario, et al.
Publicado: (2019)

Incidence of Liver Damage of Uncertain Origin in HIV Patients Not Co-Infected with HCV/HBV
por: Rivero-Juárez, Antonio, et al.
Publicado: (2013)

IFNL4 ss469415590 Variant Shows Similar Performance to rs12979860 as Predictor of Response to Treatment against Hepatitis C Virus Genotype 1 or 4 in Caucasians
por: Real, Luis M., et al.
Publicado: (2014)

What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis
por: Skaathun, Britt, et al.
Publicado: (2020)

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients
por: Núñez-Torres, Rocío, et al.
Publicado: (2016)

CD46 Genetic Variability and HIV-1 Infection Susceptibility
por: Serrano-Rísquez, Carmen, et al.
Publicado: (2021)

Limited Value of Single Sampling for IgM Antibody Determination as a Diagnostic Approach for Acute Hepatitis E Virus Infection
por: Rivero-Juarez, Antonio, et al.
Publicado: (2021)

Temporal changes in the genotypes of Paslahepevirus balayani in southern Spain and their possible link with changes in pig trade imports
por: Lopez-Lopez, Pedro, et al.
Publicado: (2023)

Optimization of the molecular diagnosis of the acute hepatitis E virus infection
por: Lopez‐Lopez, Pedro, et al.
Publicado: (2023)

Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
por: Macías, Juan, et al.
Publicado: (2021)

Using opportunistic sightings to infer differential spatio-temporal use of western Mediterranean waters by the fin whale
por: Torreblanca, Estefanía, et al.
Publicado: (2019)

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis
por: Merchante, Nicolás, et al.
Publicado: (2015)

Epidemiological survey and risk factors associated with Paslahepevirus balayani in equines in Europe
por: Caballero-Gómez, Javier, et al.
Publicado: (2023)

Natural Killer KIR3DS1 Is Closely Associated with HCV Viral Clearance and Sustained Virological Response in HIV/HCV Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2013)

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection
por: Macías, Juan, et al.
Publicado: (2015)

Seroreversion of IgG anti‐HEV in HIV cirrhotic patients: A long‐term multi‐sampling longitudinal study
por: López‐López, Pedro, et al.
Publicado: (2022)

Factors associated with the differential distribution of cetaceans linked with deep habitats in the Western Mediterranean Sea
por: Torreblanca, Estefanía, et al.
Publicado: (2022)

Epidemiological survey and risk factors associated with hepatitis E virus in small ruminants in southern Spain
por: Caballero‐Gómez, Javier, et al.
Publicado: (2022)

Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release
por: Corma, Avelino, et al.
Publicado: (2022)

Mutations in the Progesterone Receptor (PROGINS) May Reduce the Symptoms of Acute Hepatitis E and Protect Against Infection
por: López-López, Pedro, et al.
Publicado: (2019)

Hepatitis E virus in the endangered Iberian lynx (Lynx pardinus)
por: Caballero‐Gómez, Javier, et al.
Publicado: (2022)

Fiebre paratifoidea dos meses después de un viaje a la India
por: Recio, María Dolores Ortega, et al.
Publicado: (2021)

Role of Hepatitis E Virus Infection in Acute-on-Chronic Liver Failure
por: Frias, Mario, et al.
Publicado: (2018)

Hepatitis E Infection in HIV-Infected Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2019)

Low Muscle Mass Is Associated with Poorer Glycemic Control and Higher Oxidative Stress in Older Patients with Type 2 Diabetes
por: Alabadi, Blanca, et al.
Publicado: (2023)

HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2014)

Liver Stiffness Using Transient Elastography is Applicable to Canines for Hepatic Disease Models
por: Rivero-Juárez, Antonio, et al.
Publicado: (2012)

Prevalence of hepatitis E virus infection in wild boars from Spain: a possible seasonal pattern?
por: Rivero-Juarez, Antonio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ts16nj2ehd26po41u2af40644u